相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15
Joan Teyra et al.
STRUCTURE (2019)
Cytotoxicity of selected Ethiopian medicinal plants used in traditional breast cancer treatment against breast-derived cell lines
Tuasha Nigatu et al.
Journal of Medicinal Plants Research (2019)
Plant lectins in cancer therapeutics: Targeting apoptosis and autophagy-dependent cell death
Sujit K. Bhutia et al.
PHARMACOLOGICAL RESEARCH (2019)
Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery
Fernanda Majolo et al.
PHYTOCHEMISTRY LETTERS (2019)
Direct measurement of deubiquitinating enzyme activity in intact cells using a protease-resistant, cell-permeable, peptide-based reporter
Nora Safa et al.
BIOCHEMICAL ENGINEERING JOURNAL (2019)
Antiproliferative Effect of Trifolium Pratens L. Extract in Human Breast Cancer Cells
Mozafar Khazaei et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2019)
The DESIGNER Approach Helps Decipher the Hypoglycemic Bioactive Principles of Artemisia dracunculus (Russian Tarragon)
Yongmei Yu et al.
JOURNAL OF NATURAL PRODUCTS (2019)
OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR
Linlin Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
An Extract of Artemisia dracunculus L. Promotes Psychological Resilience in a Mouse Model of Depression
Jun Wang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance
Nicholas Nikesitch et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)
MTT assay to evaluate the cytotoxic potential of a drug
Ashutosh Bahuguna et al.
BANGLADESH JOURNAL OF PHARMACOLOGY (2017)
Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives
Lalitha Simon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Deubiquitinases (DUBs) and DUB inhibitors: a patent review
Pershang Farshi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Mechanism of UCH-L5 Activation and Inhibition by DEUBAD Domains in RPN13 and INO80G
Danny D. Sahtoe et al.
MOLECULAR CELL (2015)
Layers of DUB regulation
Danny D. Sahtoe et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Allosteric regulation of deubiquitylase activity through ubiquitination
Serena Faggiano et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
Ze Tian et al.
BLOOD (2014)
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
Paul G. Richardson et al.
BLOOD (2014)
An ethanolic extract of Artemisia dracunculus L. regulates gene expression of ubiquitin-proteasome system enzymes in skeletal muscle: Potential role in the treatment of sarcopenic obesity
Heather Kirk-Ballard et al.
NUTRITION (2014)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6
Francesca Nazio et al.
NATURE CELL BIOLOGY (2013)
An Extract of Artemisia dracunculus L. Inhibits Ubiquitin-Proteasome Activity and Preserves Skeletal Muscle Mass in a Murine Model of Diabetes
Heather Kirk-Ballard et al.
PLOS ONE (2013)
Proteasome deubiquitinases as novel targets for cancer therapy
Padraig D'Arcy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L
David M. Ribnicky et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Frederic Colland et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Breaking the chains: structure and function of the deubiquitinases
David Komander et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture
Zhong Q. Wang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Strategies for assessment of botanical action on metabolic syndrome in the mouse and evidence for a genotype-specific effect of Russian tarragon in the regulation of insulin sensitivity
Aamir R. Zuberi
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
A natural history of botanical therapeutics
Barbara Schmidt et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Molecular origins of cancer: Oncogenes and cancer
Carlo M. Croce
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line
Dmitry Govorko et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
Deborah J. Kuhn et al.
BLOOD (2007)
Proteasome inhibitor, bortezomib, for myeloma and lymphoma
Kensei Tobinai
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2007)
Antihyperglycemic activity of Tarralin™, an ethanolic extract of Artemisia dracunculus L.
D. M. Ribnicky et al.
PHYTOMEDICINE (2006)
Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus
Sithes Logendra et al.
PHYTOCHEMISTRY (2006)
Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A review
Manfred Dietel et al.
VIRCHOWS ARCHIV (2006)
Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8
XL Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
分享论文
